Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CALL
Prothena Corp
PRTA
$449M
| $1.42M | ﹤0.01% |
90,000
+88,900
| +8,082% | +$953K |
|
3302
Galicia Financial Group
GGAL
$7.51B
| $1.42M | ﹤0.01% |
87,632
+28,101
| +47% | +$371K |
|
3303
Paylocity
PCTY
$8.04B
| $1.42M | ﹤0.01% |
11,766
-6,098
| -34% | -$668K |
|
|
PGTI
3304
DELISTED
PGT, Inc.
PGTI
| $1.42M | ﹤0.01% |
95,311
+23,546
| +33% | +$374K |
|
|
SRC
3305
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.42M | ﹤0.01% |
28,843
+22,705
| +370% | +$1.13M |
|
3306
Customers Bancorp
CUBI
$2.77B
| $1.42M | ﹤0.01% |
59,475
-3,909
| -6% | -$89.8K |
|
3307
Theravance Biopharma
TBPH
$877M
| $1.42M | ﹤0.01% |
54,708
+9,628
| +21% | +$187K |
|
3308
PUT
Phillips 66
PSX
$82B
| $1.42M | ﹤0.01% |
12,700
+1,600
| +14% | +$180K |
|
3309
Euronet Worldwide
EEFT
$2.73B
| $1.41M | ﹤0.01% |
8,969
-31,408
| -78% | -$4.74M |
|
3310
Cohu
COHU
$2.45B
| $1.41M | ﹤0.01% |
61,582
+19,291
| +46% | +$347K |
|
3311
Innoviva
INVA
$1.53B
| $1.41M | ﹤0.01% |
99,533
-82,953
| -45% | -$1.02M |
|
3312
Brookdale Senior Living
BKD
$3.43B
| $1.41M | ﹤0.01% |
193,577
+92,432
| +91% | +$687K |
|
3313
PUT
NIO
NIO
$11.5B
| $1.41M | ﹤0.01% |
350,000
+13,000
| +4% | +$26.1K |
|
3314
Greif
GEF
$5.07B
| $1.4M | ﹤0.01% |
31,736
+15,565
| +96% | +$644K |
|
3315
United Fire Group
UFCS
$1.41B
| $1.4M | ﹤0.01% |
32,065
+10,907
| +52% | +$488K |
|
3316
Veracyte
VCYT
$3.71B
| $1.4M | ﹤0.01% |
50,182
+16,650
| +50% | +$431K |
|
|
MDP
3317
DELISTED
Meredith Corporation
MDP
| $1.4M | ﹤0.01% |
43,141
+8,111
| +23% | +$289K |
|
3318
CALL
Eldorado Gold
EGO
$9.37B
| $1.4M | ﹤0.01% |
174,340
-16,200
| -9% | -$126K |
|
3319
CALL
Deutsche Bank
DB
$70.7B
| $1.4M | ﹤0.01% |
179,600
+11,400
| +7% | +$85.5K |
|
3320
CALL
Teradata
TDC
$2.51B
| $1.4M | ﹤0.01% |
52,200
+18,700
| +56% | +$520K |
|
3321
PetMed Express
PETS
$42.1M
| $1.4M | ﹤0.01% |
59,346
-12,771
| -18% | -$286K |
|
|
MFGP
3322
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.4M | ﹤0.01% |
99,407
+66,821
| +205% | +$925K |
|
3323
CALL
S&P Global
SPGI
$119B
| $1.39M | ﹤0.01% |
5,100
-600
| -11% | -$156K |
|
|
CMA
3324
CALL
DELISTED
Comerica
CMA
| $1.39M | ﹤0.01% |
19,400
-4,600
| -19% | -$316K |
|
3325
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
| $1.39M | ﹤0.01% |
8,500
-2,800
| -25% | -$439K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.